IFN-γ immune priming of macrophages in vivo induces prolonged STAT1 binding and protection against Cryptococcus neoformans

PLoS Pathog. 2018 Oct 10;14(10):e1007358. doi: 10.1371/journal.ppat.1007358. eCollection 2018 Oct.

Abstract

Development of vaccines against opportunistic infections is difficult as patients most at risk of developing disease are deficient in aspects of the adaptive immune system. Here, we utilized an experimental immunization strategy to induce innate memory in macrophages in vivo. Unlike current trained immunity models, we present an innate memory-like phenotype in macrophages that is maintained for at least 70 days post-immunization and results in complete protection against secondary challenge in the absence of adaptive immune cells. RNA-seq analysis of in vivo IFN-γ primed macrophages revealed a rapid up-regulation of IFN-γ and STAT1 signaling pathways following secondary challenge. The enhanced cytokine recall responses appeared to be pathogen-specific, dependent on changes in histone methylation and acetylation, and correlated with increased STAT1 binding to promoter regions of genes associated with protective anti-fungal immunity. Thus, we demonstrate an alternative mechanism to induce macrophage innate memory in vivo that facilitates pathogen-specific vaccine-mediated immune responses.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Cryptococcosis / immunology
  • Cryptococcosis / microbiology
  • Cryptococcosis / prevention & control*
  • Cryptococcus neoformans / immunology*
  • Cytokines / metabolism
  • Female
  • Interferon-gamma / metabolism*
  • Lung Diseases, Fungal / immunology
  • Lung Diseases, Fungal / microbiology
  • Lung Diseases, Fungal / prevention & control*
  • Macrophage Activation / immunology*
  • Macrophages, Alveolar / immunology*
  • Mice
  • Mice, Inbred BALB C
  • STAT1 Transcription Factor / metabolism*
  • Signal Transduction

Substances

  • Cytokines
  • STAT1 Transcription Factor
  • Stat1 protein, mouse
  • Interferon-gamma